Generic Portal

— Research Explorer

Immune monitoring during therapy reveals activitory and regulatory immune responses in high-risk neuroblastoma

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.3390/cancers13092096
Final published version

Celina L. Szanto
Annelisa M. Cornel
Sara M. Tamminga
Eveline M. Delemarre
Coco C.H. de Koning
Denise A.M.H. van den Beemt
Ester Dunnebach
Michelle L. Tas
Miranda P. Dierselhuis
Lieve G.A.M. Tytgat
Max M. van Noesel
Kathelijne C.J.M. Kraal
Jaap Jan Boelens
Alwin D.R. Huitema
Stefan Nierkens

Original language	English
Article number	2096
Journal	Cancers
Volume	13
Issue number	9
DOIs	https://doi.org/10.3390/cancers13092096
Publication status	Published - 1 May 2021

Research areas

Anti-GD2, ASCT, Dinutuximab, GM-CSF, IL-2, Immune monitoring, Immunotherapy, Neuroblastoma

ID: 28493307